BCG vaccination of neonatal calves: Potential roles for innate immune cells in the induction of protective immunity

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 35, Issue 3, 2012, Pages 219-226

  Siddiqui, Nazneen ^a,b   Price, Sally ^a,c   Hope, Jayne ^a,d  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b Oxford Immunotec   (United Kingdom)

^c Health Interactions   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

T cell; Bacille Calmette Guerin; Dendritic cell; Natural killer cell; Neonatal vaccination

Indexed keywords

BCG VACCINE; CD2 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; WORK SHOP CLUSTER 1 PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CARE; ANIMAL HEALTH; ARTICLE; BACTERIAL VIRULENCE; BCG VACCINATION; BOVINE TUBERCULOSIS; CALF (BOVINE); CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DRUG EFFICACY; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; INFECTION PREVENTION; INNATE IMMUNITY; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; NATURAL KILLER CELL; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANIMALS, NEWBORN; ANTIGEN-PRESENTING CELLS; BCG VACCINE; CATTLE; IMMUNITY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MYCOBACTERIUM BOVIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS, BOVINE; VACCINATION;

ANIMALIA; BOS; BOVINAE; MYCOBACTERIUM BOVIS;

EID: 84859713195     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2011.11.003     Document Type: Article

References (102)

1. Colditz G.A., Berkey C.S., Mosteller F., Brewer T.F., Wilson M.E., Burdick E., et al. The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995, 96:29-35.
2. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346:1339-1345.
3. Trunz B.B., Fine P., Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006, 367:1173-1180.
4. Bonifachich E., Chort M., Astigarraga A., Diaz N., Brunet B., Pezzotto S.M., et al. Protective effect of Bacillus Calmette-Guerin (BCG) vaccination in children with extra-pulmonary tuberculosis, but not the pulmonary disease. A case-control study in Rosario, Argentina. Vaccine 2006, 24:2894-2899.
5. Smith N.H., Gordon S.V., de la Rua-Domenech R., Clifton-Hadley R.S., Hewinson R.G. Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis. Nat Rev Microbiol 2006, 4:670-681.
6. Buddle B.M., Wedlock D.N., Denis M., Vordermeier H.M., Hewinson R.G. Update on vaccination of cattle and wildlife populations against tuberculosis. Vet Microbiol 2011, 151:14-22.
7. Corner L.A., Costello E., O'Meara D., Lesellier S., Aldwell F.E., Singh M., et al. Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis. Vaccine 2010, 28:6265-6272.
8. Lesellier S., Palmer S., Gowtage-Sequiera S., Ashford R., Dalley D., Dave D., et al. Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCG. Vaccine 2011, 29:3782-3790.
9. Chambers M.A., Rogers F., Delahay R.J., Lesellier S., Ashford R., Dalley D., et al. Bacillus Calmette-Guerin vaccination reduces the severity and progression of tuberculosis in badgers. Proc Biol Sci 2011, 278:1913-1920.
10. McShane H. Tuberculosis vaccines: beyond Bacille Calmette-Guerin. Philos Trans R Soc Lond B Biol Sci 2011, 366:2782-2789.
11. Vordermeier H.M., Villarreal-Ramos B., Cockle P.J., McAulay M., Rhodes S.G., Thacker T., et al. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun 2009, 77:3364-3373.
12. McShane H., Pathan A.A., Sander C.R., Keating S.M., Gilbert S.C., Huygen K., et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 2004, 10:1240-1244.
13. Cosivi O., Grange J.M., Daborn C.J., Raviglione M.C., Fujikura T., Cousins D., et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 1998, 4:59-70.
14. Smith N.H., Hewinson R.G., Kremer K., Brosch R., Gordon S.V. Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol 2009, 7:537-544.
15. Buddle B.M., Skinner M.A., Wedlock D.N., de Lisle G.W., Vordermeier H.M., Glyn Hewinson R. Cattle as a model for development of vaccines against human tuberculosis. Tuberculosis (Edinb) 2005, 85:19-24.
16. Waters W.R., Palmer M.V., Thacker T.C., Davis W.C., Sreevatsan S., Coussens P., et al. Tuberculosis immunity: opportunities from studies with cattle. Clin Dev Immunol 2011, 2011:768542.
17. Endsley J.J., Waters W.R., Palmer M.V., Nonnecke B.J., Thacker T.C., Jacobs W.R., et al. The calf model of immunity for development of a vaccine against tuberculosis. Vet Immunol Immunopathol 2009, 128:199-204.
18. Brandt L., Feino Cunha J., Weinreich Olsen A., Chilima B., Hirsch P., Appelberg R., et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002, 70:672-678.
19. Stanford J.L., Shield M.J., Rook G.A. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 1981, 62:55-62.
20. Palmer C.E., Long M.W. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis 1966, 94:553-568.
21. Buddle B.M., Wedlock D.N., Parlane N.A., Corner L.A., De Lisle G.W., Skinner M.A. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun 2003, 71:6411-6419.
22. + T lymphocytes. Eur J Immunol 2001, 31:1531-1535.
23. Orme I.M., Roberts A.R., Collins F.M. Lack of evidence for a reduction in the efficacy of subcutaneous BCG vaccination in mice infected with nontuberculous mycobacteria. Tubercle 1986, 67:41-46.
24. Hope J.C., Thom M.L., Villarreal-Ramos B., Vordermeier H.M., Hewinson R.G., Howard C.J. Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle. Clin Exp Immunol 2005, 141:432-439.
25. Hope J.C., Thom M.L., Villarreal-Ramos B., Vordermeier H.M., Hewinson R.G., Howard C.J. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin Exp Immunol 2005, 139:48-56.
26. Buddle B.M., Wards B.J., Aldwell F.E., Collins D.M., de Lisle G.W. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 2002, 20:1126-1133.
27. Wedlock D.N., Denis M., Vordermeier H.M., Hewinson R.G., Buddle B.M. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis. Vet Immunol Immunopathol 2007, 118:50-58.
28. Hope J.C., Thom M.L., McAulay M., Mead E., Vordermeier H.M., Clifford D., et al. Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish. Clin Vaccine Immunol 2011, 18:373-379.
29. Ameni G., Vordermeier M., Aseffa A., Young D.B., Hewinson R.G. Field evaluation of the efficacy of Mycobacterium bovis Bacillus Calmette-Guerin against bovine tuberculosis in neonatal calves in Ethiopia. Clin Vaccine Immunol 2010, 17:1533-1538.
30. Lopez-Valencia G., Renteria-Evangelista T., Williams Jde J., Licea-Navarro A., Mora-Valle Ade L., Medina-Basulto G. Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis. Res Vet Sci 2010, 88:44-49.
31. Whelan A.O., Wright D.C., Chambers M.A., Singh M., Hewinson R.G., Vordermeier H.M. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Vaccine 2008, 26:166-173.
32. Price S.J., Sopp P., Howard C.J., Hope J.C. Workshop cluster 1+ gammadelta T-cell receptor T cells from calves express high levels of interferon-gamma in response to stimulation with interleukin-12 and -18. Immunology 2007, 120:57-65.
33. Graham E.M., Thom M.L., Howard C.J., Boysen P., Storset A.K., Sopp P., et al. Natural killer cell number and phenotype in bovine peripheral blood is influenced by age. Vet Immunol Immunopathol 2009, 132:101-108.
34. Kulberg S., Boysen P., Storset A.K. Reference values for relative numbers of natural killer cells in cattle blood. Dev Comp Immunol 2004, 28:941-948.
35. Marino S., Pawar S., Fuller C.L., Reinhart T.A., Flynn J.L., Kirschner D.E. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J Immunol 2004, 173:494-506.
36. Abdi K., Singh N., Matzinger P. T-cell control of IL-12p75 production. Scand J Immunol 2006, 64:83-92.
37. Walzer T., Jaeger S., Chaix J., Vivier E. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 2007, 19:365-372.
38. Boysen P., Storset A.K. Bovine natural killer cells. Vet Immunol Immunopathol 2009, 130:163-177.
39. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
40. Marquardt N., Wilk E., Pokoyski C., Schmidt R.E., Jacobs R. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population. Eur J Immunol 2010, 40:1428-1439.
41. Watt S.V., Andrews D.M., Takeda K., Smyth M.J., Hayakawa Y. IFN-gamma-dependent recruitment of mature CD27(high) NK cells to lymph nodes primed by dendritic cells. J Immunol 2008, 181:5323-5330.
42. Boysen P., Olsen I., Berg I., Kulberg S., Johansen G.M., Storset A.K. Bovine CD2-/NKp46+ cells are fully functional natural killer cells with a high activation status. BMC Immunol 2006, 7:10.
43. Storset A.K., Kulberg S., Berg I., Boysen P., Hope J.C., Dissen E. NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics. Eur J Immunol 2004, 34:669-676.
44. Boysen P., Gunnes G., Pende D., Valheim M., Storset A.K. Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties. Dev Comp Immunol 2008, 32:773-783.
45. Chauveau A., Aucher A., Eissmann P., Vivier E., Davis D.M. Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc Natl Acad Sci USA 2010, 107:5545-5550.
46. Culley F.J., Johnson M., Evans J.H., Kumar S., Crilly R., Casasbuenas J., et al. Natural killer cell signal integration balances synapse symmetry and migration. PLoS Biol 2009, 7:e1000159.
47. Davis D.M., Dustin M.L. What is the importance of the immunological synapse?. Trends Immunol 2004, 25:323-327.
48. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998, 282:121-125.
49. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999, 162:4511-4520.
50. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
51. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
52. Dhiman R., Indramohan M., Barnes P.F., Nayak R.C., Paidipally P., Rao L.V., et al. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol 2009, 183:6639-6645.
53. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004, 5:1260-1265.
54. Chijioke O., Munz C. Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo. J Biomed Biotechnol 2011, 2011:251679.
55. Boysen P., Eide D.M., Storset A.K. Natural killer cells in free-living Mus musculus have a primed phenotype. Mol Ecol 2011.
56. Wehner R., Dietze K., Bachmann M., Schmitz M. The bidirectional crosstalk between human dendritic cells and natural killer cells. J Innate Immun 2011, 3:258-263.
57. Sun J.C., Lopez-Verges S., Kim C.C., DeRisi J.L., Lanier L.L. NK cells and immune "memory" J Immunol 2011, 186:1891-1897.
58. Sun J.C., Lanier L.L. Versatility in NK cell memory. Immunol Cell Biol 2011, 89:327-329.
59. Paust S., von Andrian U.H. Natural killer cell memory. Nat Immunol 2011, 12:500-508.
60. Feng C.G., Kaviratne M., Rothfuchs A.G., Cheever A., Hieny S., Young H.A., et al. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol 2006, 177:7086-7093.
61. Junqueira-Kipnis A.P., Kipnis A., Jamieson A., Juarrero M.G., Diefenbach A., Raulet D.H., et al. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol 2003, 171:6039-6045.
62. Lande R., Giacomini E., Grassi T., Remoli M.E., Iona E., Miettinen M., et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 2003, 170:1174-1182.
63. Vankayalapati R., Wizel B., Weis S.E., Safi H., Lakey D.L., Mandelboim O., et al. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2002, 168:3451-3457.
64. Esin S., Batoni G., Counoupas C., Stringaro A., Brancatisano F.L., Colone M., et al. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect Immun 2008, 76:1719-1727.
65. Marcenaro E., Ferranti B., Falco M., Moretta L., Moretta A. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int Immunol 2008, 20:1155-1167.
66. Olsen I., Boysen P., Kulberg S., Hope J.C., Jungersen G., Storset A.K., et al. Bovine NK cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70. Infect Immun 2005, 73:5628-5635.
67. Denis M., Keen D.L., Parlane N.A., Storset A.K., Buddle B.M. Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages. Tuberculosis (Edinb) 2007, 87:53-62.
68. Endsley J.J., Endsley M.A., Estes D.M. Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. J Leukoc Biol 2006, 79:71-79.
69. Elhmouzi-Younes J., Storset A.K., Boysen P., Laurent F., Drouet F. Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation. Vet Res 2009, 40:54.
70. Sundstrom Y., Nilsson C., Lilja G., Karre K., Troye-Blomberg M., Berg L. The expression of human natural killer cell receptors in early life. Scand J Immunol 2007, 66:335-344.
71. Erkeller-Yuksel F.M., Deneys V., Yuksel B., Hannet I., Hulstaert F., Hamilton C., et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992, 120:216-222.
72. Kampen A.H., Olsen I., Tollersrud T., Storset A.K., Lund A. Lymphocyte subpopulations and neutrophil function in calves during the first 6 months of life. Vet Immunol Immunopathol 2006, 113:53-63.
73. Hope J.C., Sopp P., Howard C.J. NK-like CD8(+) cells in immunologically naive neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG. J Leukoc Biol 2002, 71:184-194.
74. Hope J.C., Thom M.L., McCormick P.A., Howard C.J. Interaction of antigen presenting cells with mycobacteria. Vet Immunol Immunopathol 2004, 100:187-195.
75. Watkins M.L., Semple P.L., Abel B., Hanekom W.A., Kaplan G., Ress S.R. Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol 2008, 15:1666-1673.
76. Semple P.L., Watkins M., Davids V., Krensky A.M., Hanekom W.A., Kaplan G., et al. Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth. Clin Dev Immunol 2011, 2011:438463.
77. Davis W.C., Brown W.C., Hamilton M.J., Wyatt C.R., Orden J.A., Khalid A.M., et al. Analysis of monoclonal antibodies specific for the gamma delta TcR. Vet Immunol Immunopathol 1996, 52:275-283.
78. Holm D., Fink D.R., Gronlund J., Hansen S., Holmskov U. Cloning and characterization of SCART1, a novel scavenger receptor cysteine-rich type I transmembrane molecule. Mol Immunol 2009, 46:1663-1672.
79. Rogers A.N., Vanburen D.G., Zou B., Lahmers K.K., Herzig C.T., Brown W.C., et al. Characterization of WC1 co-receptors on functionally distinct subpopulations of ruminant gamma delta T cells. Cell Immunol 2006, 239:151-161.
80. Rogers A.N., VanBuren D.G., Hedblom E., Tilahun M.E., Telfer J.C., Baldwin C.L. Function of ruminant gammadelta T cells is defined by WC1.1 or WC1.2 isoform expression. Vet Immunol Immunopathol 2005, 108:211-217.
81. Rogers A.N., Vanburen D.G., Hedblom E.E., Tilahun M.E., Telfer J.C., Baldwin C.L., et al. Gammadelta T cell function varies with the expressed WC1 coreceptor. J Immunol 2005, 174:3386-3393.
82. Guzman E., Price S., Poulsom H., Hope J. Bovine gammadelta T cells: cells with multiple functions and important roles in immunity. Vet Immunol Immunopathol 2011.
83. Moser B., Eberl M. Gammadelta T-APCs: a novel tool for immunotherapy?. Cell Mol Life Sci 2011, 68:2443-2452.
84. Kabelitz D. Gammadelta T-cells: cross-talk between innate and adaptive immunity. Cell Mol Life Sci 2011, 68:2331-2333.
85. Pollock J.M., Welsh M.D. The WC1(+) gammadelta T-cell population in cattle: a possible role in resistance to intracellular infection. Vet Immunol Immunopathol 2002, 89:105-114.
86. Meraviglia S., El Daker S., Dieli F., Martini F., Martino A. Gammadelta T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection. Clin Dev Immunol 2011, 2011:587315.
87. Welsh M.D., Kennedy H.E., Smyth A.J., Girvin R.M., Andersen P., Pollock J.M. Responses of bovine WC1(+) gammadelta T cells to protein and nonprotein antigens of Mycobacterium bovis. Infect Immun 2002, 70:6114-6120.
88. Kennedy H.E., Welsh M.D., Bryson D.G., Cassidy J.P., Forster F.I., Howard C.J., et al. Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1(+) gamma delta T cells. Infect Immun 2002, 70:1488-1500.
89. Pollock J.M., Pollock D.A., Campbell D.G., Girvin R.M., Crockard A.D., Neill S.D., et al. Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle. Immunology 1996, 87:236-241.
90. Buza J., Kiros T., Zerihun A., Abraham I., Ameni G. Vaccination of calves with Mycobacteria bovis Bacilli Calmete Guerin (BCG) induced rapid increase in the proportion of peripheral blood gammadelta T cells. Vet Immunol Immunopathol 2009, 130:251-255.
91. Mazzola T.N., Da Silva M.T., Moreno Y.M., Lima S.C., Carniel E.F., Morcillo A.M., et al. Robust gammadelta+ T cell expansion in infants immunized at birth with BCG vaccine. Vaccine 2007, 25:6313-6320.
92. Price S., Davies M., Villarreal-Ramos B., Hope J. Differential distribution of WC1(+) gammadelta TCR(+) T lymphocyte subsets within lymphoid tissues of the head and respiratory tract and effects of intranasal M. bovis BCG vaccination. Vet Immunol Immunopathol 2010, 136:133-137.
93. Dieli F., Ivanyi J., Marsh P., Williams A., Naylor I., Sireci G., et al. Characterization of lung {gamma}{delta} T cells following intranasal infection with Mycobacterium bovis Bacillus Calmette-Guerin. J Immunol 2003, 170:463-469.
94. Feau S., Facchinetti V., Granucci F., Citterio S., Jarrossay D., Seresini S., et al. Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood 2005, 105:697-702.
95. Price S.J., Hope J.C. Enhanced secretion of interferon-gamma by bovine gammadelta T cells induced by coculture with Mycobacterium bovis-infected dendritic cells: evidence for reciprocal activating signals. Immunology 2009, 126:201-208.
96. Caccamo N., Sireci G., Meraviglia S., Dieli F., Ivanyi J., Salerno A. Gammadelta T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis. Eur J Immunol 2006, 36:2681-2690.
97. Cooper A.M. T cells in mycobacterial infection and disease. Curr Opin Immunol 2009, 21:378-384.
98. Cooper A.M. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009, 27:393-422.
99. + T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guerin vaccinated and nonvaccinated cattle. Scand J Immunol 2000, 52:285-291.
100. Seder R.A., Darrah P.A., Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008, 8:247-258.
101. + memory T lymphocyte populations. Eur J Immunol 2007, 37:3089-3100.
102. Kaveh D.A., Bachy V.S., Hewinson R.G., Hogarth P.J. Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge. PLoS One 2011, 6:e21566.